Targets › TOPI
1 program from 1 company in 1 trial: 1 Phase 2; Oncology.
Open in Phaseline: the race on TOPI, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Grupo Espanol Multidisciplinario del Cancer Digestivo | LIFEPEARLS-Irinotecan Chemoembolization with irinotecan-loaded hydrogel microspheres for intra-arterial hepatic | TOPI | Phase 2 | Colorectal Cancer Metastatic | – |
Colorectal Cancer Metastatic (1)
mixed (1)
Grupo Espanol Multidisciplinario del Cancer Digestivo (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.